alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit31.1**

**CERTIFICATIONS PURSUANT TO**

**SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

I, JamesS. Osterman, certify that:

1.             I have reviewed this quarterlyreport on Form 10-Q for the period ended March 31, 2005 of BlountInternational, Inc.;

2.             Based on my knowledge, thisquarterly report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading withrespect to the period covered by this quarterly report;

3.             Based on my knowledge, thefinancial statements, and other financial information included in thisquarterly report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this quarterly report;

4.             The registrant’s other certifyingofficer and I are responsible for establishing and maintaining disclosurecontrols and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have:

                (a) designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

                (b) evaluated the effectivenessof the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on suchevaluation; and

                (c) disclosed in this report anychange in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

5.             The registrant’s other certifyingofficer and I have disclosed, based on our most recent evaluation of internalcontrol over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors:

                (a) all significant deficienciesand material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financialinformation; and

                (b) any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal controls.

Date: May10, 2005

 

 
| /s/ James S. Osterman     |   |
|---------------------------|--------|
| James S. Osterman         |   |
| Chairman of the Board and |   |
| Chief Executive Officer   |   |

 

----
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 19

- 0856 V

UNPUBLISHED

BETTY MYERS

- NOBLE

,

Petitioner,

v.

SECRETARY OF HEALTH AND

HUMAN SERVICES,

Respondent. Chief Special Master Corcoran

Filed: October 5, 2020

Special Processing Unit (SPU) ;

Rul ing on Entitlement; Concession;

Table Injury; Influenza (Flu) Vaccine;
Shoulder Injury Related to Vaccine

Administration (SIRVA)

Paul R. Brazil, Muller Brazil, LLP, Dresher, PA , for petitioner.

Adriana Ruth Teitel

, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT 1

On June 10, 2019

, Betty Myers

- No ble filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa

- 10, et seq

. 2 (the “Vaccine Act”). Petitioner alleges that she suffered a shoulder inju ry related to vaccine administration ( “ SIRVA ” ) as a result of an influenza vaccination she received on

December 13, 201 7 . Petit ion at 1 . The case was assigned to the Special Processing Unit of the Office of Special Masters.

On October 5, 2020

, R espondent filed his Rule 4(c) report in which he concedes

that P etitioner is entitled to compensa tion in this case. Respondent’s Rule 4(c) Report at 1. Specifically, R espondent “ has conc luded that [P]etitioner ’ s medical course is

consistent with SIRVA as defined by the Vaccine Injury Table and correspond ing

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E

- Government Act

of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means the ruling will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,

the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that

the identified material fits within this definition, I will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99

- 660, 100 Stat. 3755

. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subpara graph of 42 U.S.C. § 300aa

(2012 ).2

Qualifications and Aids to Interpretation

. ” Id. at 5 . Respondent further agrees that

Petitioner suffered the residual effects of her condition for more than six months

. Id.

In view of R espondent’s position and the evidence of record, I find that

P etitioner is entitle d to compensation.

IT IS SO ORDERED.

s/ Brian H. Corcoran

Brian H. Corcoran

Chief Special Master
Exhibit 99.1

                        CERTIFICATION OF PERIODIC REPORT

I, Seymour Flug, the President & Chief Executive Officer of Integrated Health
Technologies, Inc. (the "Company"), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)   the Annual Report on Form 10-KSB of the Company for the annual period
      ended June 30, 2002 (the "Report") fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
      78m or 78o(d)); and

(2)   the information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.

Dated:   September 9, 2002


                                             By: /s/ Seymour Flug
                                                --------------------------
                                             Seymour E. Flug
                                             President & Chief Executive Officer


                        CERTIFICATION OF PERIODIC REPORT

I, Eric Friedman, the Vice President and Chief Financial Officer of Integrated
Health Technologies, Inc. (the "Company"), certify, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)   the Annual Report on Form 10-KSB of the Company for the annual period
      ended June 30, 2002 (the "Report") fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
      78m or 78o(d)); and

(2)   the information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.

Dated:   September 9, 2002


                                             By: /s/ Eric Friedman
                                                --------------------------
                                             Eric Friedman
                                             Vice President and Chief Financial
                                             Officer
## COURT OF APPEALS SECOND DISTRICT OF TEXAS FORT WORTH
NO. 02
- 18
- 00180
- CR

HARRY C. WASHINGTON APPELLANT
V.
THE STATE OF TEXAS STATE

---------- FROM THE 297TH DISTRICT COURT OF TARRANT COUNTY TRIAL COURT NO. 1458 141D

---------- 

### MEMORANDUM OPINION 1

---------- On April 27, 2018, we notified Appellant Harry C. Wa shington of our concern that we lacked jurisdiction over this appeal because he was attempting to appeal from a judgment of acquittal. 2 We generally have jurisdiction to

1 See Tex. R. App. P. 47.4.

2 Appellant’s companion case in cause number 02

- 18

- 00181

- CR rem ains pending because that appeal is from a judgment of conviction.2 consider an appeal in a criminal case only when there has been a final judgment
of co nviction. See Tex. Code Crim. Proc. Ann. art. 44.02 (West 2018); McKown
v. State , 915 S.W.2d 160, 161 (Tex. App.

— Fort Worth 1996, no pet.).
We inf ormed Appellant that his appeal would be dismissed for want of jurisdiction unless he or any party desiring t o continue the appeal filed with this court, on or before May 7, 2018 , a response showing grou nds for continuing the appeal

. See Tex. R. App. P

. 43.2(f), 44.3. No response has been filed. Accordingly, we dismiss the appeal. See Tex. R. App. P. 43.2(f).

/s/ Bonnie Sudderth
BONNIE SUDDERTH CHIEF JUSTICE PANEL: SUDDERTH, C.J.; WALKER and MEIER, JJ.
DO NOT PUBLISH Tex. R. App. P. 47.2(b)
DELIVERED: June 7, 2018
# L_2009279EN.01000101.xml

| 24.10.2009 | EN | Official Journal of the European Union | L 279/1 |
| --- | --- | --- | --- |

24.10.2009

EN

Official Journal of the European Union

L 279/1

---

COMMISSION REGULATION (EC) No 1003/2009

of 23 October 2009

establishing the standard import values for determining the entry price of certain fruit and vegetables

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EC) No 1234/2007 of 22 October 2007 establishing a common organisation of agricultural markets and on specific provisions for certain agricultural products (Single CMO Regulation) (1),

Having regard to Commission Regulation (EC) No 1580/2007 of 21 December 2007 laying down implementing rules for Council Regulations (EC) No 2200/96, (EC) No 2201/96 and (EC) No 1182/2007 in the fruit and vegetable sector (2), and in particular Article 138(1) thereof,

Whereas:

Regulation (EC) No 1580/2007 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations, the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products and periods stipulated in Annex XV, Part A thereto,

HAS ADOPTED THIS REGULATION:

Article 1

The standard import values referred to in Article 138 of Regulation (EC) No 1580/2007 are fixed in the Annex hereto.

Article 2

This Regulation shall enter into force on 24 October 2009.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 23 October 2009.

For the Commission

Jean-Luc DEMARTY

Director-General for Agriculture and Rural Development

---

(1)  
  OJ L 299, 16.11.2007, p. 1.

1

(2)  
  OJ L 350, 31.12.2007, p. 1.

2

---

ANNEX

Standard import values for determining the entry price of certain fruit and vegetables

| (EUR/100 kg) |
| --- |
| CN code | Third country code (1) | Standard import value |
| 0702 00 00 | MA | 40,1 |
| MK | 20,7 |
| TR | 69,4 |
| ZZ | 43,4 |
| 0707 00 05 | MK | 31,4 |
| TR | 112,4 |
| ZZ | 71,9 |
| 0709 90 70 | MA | 62,6 |
| TR | 114,0 |
| ZZ | 88,3 |
| 0805 50 10 | AR | 77,8 |
| TR | 77,2 |
| ZA | 79,5 |
| ZZ | 78,2 |
| 0806 10 10 | BR | 211,7 |
| TR | 114,9 |
| US | 238,2 |
| ZZ | 188,3 |
| 0808 10 80 | AU | 182,8 |
| CL | 114,8 |
| MK | 16,1 |
| NZ | 82,4 |
| US | 89,2 |
| ZA | 79,1 |
| ZZ | 94,1 |
| 0808 20 50 | CN | 59,2 |
| ZA | 70,1 |
| ZZ | 64,7 |

(EUR/100 kg)

CN code

Third country code (1)

Standard import value

0702 00 00

MA

40,1

MK

20,7

TR

69,4

ZZ

43,4

0707 00 05

MK

31,4

TR

112,4

ZZ

71,9

0709 90 70

MA

62,6

TR

114,0

ZZ

88,3

0805 50 10

AR

77,8

TR

77,2

ZA

79,5

ZZ

78,2

0806 10 10

BR

211,7

TR

114,9

US

238,2

ZZ

188,3

0808 10 80

AU

182,8

CL

114,8

MK

16,1

NZ

82,4

US

89,2

ZA

79,1

ZZ

94,1

0808 20 50

CN

59,2

ZA

70,1

ZZ

64,7

---

(1)  Nomenclature of countries laid down by Commission Regulation (EC) No 1833/2006 (OJ L 354, 14.12.2006, p. 19). Code ‘
  ZZ
  ’ stands for ‘of other origin’.

---
UNPUBLISHED

UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT

No. 08-8470

CHRISTOPHER ALLEN TODD,

Plaintiff – Appellant,

v.

GREGORY KNOWLIN, Warden; CORPORAL JONES, Officer; OFFICER TOLLER,

Defendants – Appellees,

and

SOUTH CAROLINA DEPARTMENT OF CORRECTIONS,

Defendant.

Appeal from the United States District Court for the District of South Carolina, at Beaufort. G. Ross Anderson, Jr., Senior District Judge. (9:07-cv-03990-GRA)

Submitted: April 20, 2009 Decided: May 11, 2009

Before GREGORY, SHEDD, and AGEE, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Christopher Allen Todd, Appellant Pro Se. Erin Mary Farrell, Daniel Roy Settana, Jr., MCKAY, CAUTHEN, SETTANA & STUBLEY, PA, Columbia, South Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:

Christopher Allen Todd appeals the district court’s

order accepting the recommendation of the magistrate judge and

denying relief on his 42 U.S.C. § 1983 (2000) complaint. We

have reviewed the record and find no reversible error.

Accordingly, we affirm the district court’s order. Todd v.

Knowlin , No. 9:07-cv-03990-GRA (D.S.C. Nov. 3, 2008). We

dispense with oral argument because the facts and legal

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

AFFIRMED
EXHIBIT
32.1




CERTIFICATION


OF


PRINCIPAL
EXECUTIVE OFFICER




Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of Manhattan
Pharmaceuticals, Inc. does hereby certify that, to the best of his
knowledge:


(a)      the
Quarterly Report on Form 10-Q of Manhattan Pharmaceuticals, Inc. for the quarter
ended June 30, 2010 (the “Report”) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(b)      information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of Manhattan Pharmaceuticals,
Inc.





Dated:
      August 16, 2010
                /s/
      Michael G. McGuinnessMichael
      G. McGuinnessPrincipal
      Executive and Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Interior

###### Bureau of Indian Affairs

          - [212A2100DD/AAKC001030/A0A501010.999900253G]

# AGENCY:

Bureau of Indian Affairs, Interior.

# ACTION:

Notice.

# SUMMARY:

This notice publishes the approval of the Agreement Between the Mohegan Tribe of Indians of Connecticut (Tribe) and the State of Connecticut (State) to amend the Tribe's Class III Gaming Compact (Amendment) and Memorandum of Understanding (MOU).

# DATES:

The Amendment takes effect on September 15, 2021.

# FOR FURTHER INFORMATION CONTACT:

Ms. Paula L. Hart, Director, Office of Indian Gaming, Office of the Deputy Assistant Secretary—Policy and Economic Development, Washington, DC 20240, *paula.hart@bia.gov,* (202) 219-4066.

# SUPPLEMENTARY INFORMATION:

Under section 11 of the Indian Gaming Regulatory Act (IGRA), Public Law 100-497, 25 U.S.C. 2701*et seq.,* the Secretary of the Interior shall publish in the **Federal Register** notice of approved Tribal-State compacts for the purpose of engaging in Class III gaming activities on Indian lands. As required by 25 CFR 293.4, all compacts and amendments are subject to review and approval by the Secretary. The Amendment, the MOU and the State of Connecticut House Bill No. 6451 (State Gaming Act) work in unison to provide the Mohegan Tribe and the Mashantucket Pequot Tribe       ( print page 51370)    with exclusivity for online casino gaming in the State, two of three licenses for off-reservation sports wagering, and online on-reservation casino gaming and sports wagering. The Amendment and MOU are approved.

Bryan Newland,

Assistant Secretary—Indian Affairs.

[FR Doc. 2021-19839 Filed 9-14-21; 8:45 am]

BILLING CODE 4337-15-P
[Federal Register Volume 86, Number 173 (Friday, September 10, 2021)]
[Presidential Documents]
[Page 50831]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19747]



[[Page 50829]]

Vol. 86

Friday,

No. 173

September 10, 2021

Part III





The President





-----------------------------------------------------------------------



Presidential Determination No. 2021-12 of September 7, 2021--
Continuation of the Exercise of Certain Authorities Under the Trading 
With the Enemy Act


                        Presidential Documents 



Federal Register / Vol. 86 , No. 173 / Friday, September 10, 2021 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 50831]]

                Presidential Determination No. 2021-12 of September 7, 
                2021

                
Continuation of the Exercise of Certain 
                Authorities Under the Trading With the Enemy Act

                Memorandum for the Secretary of State [and] the 
                Secretary of the Treasury

                Under section 101(b) of Public Law 95-223 (91 Stat. 
                1625; 50 U.S.C. 4305 note), and a previous 
                determination on September 9, 2020 (85 FR 57075, 
                September 14, 2020), the exercise of certain 
                authorities under the Trading With the Enemy Act is 
                scheduled to expire on September 14, 2021.

                I hereby determine that the continuation of the 
                exercise of those authorities with respect to Cuba for 
                1 year is in the national interest of the United 
                States.

                Therefore, consistent with the authority vested in me 
                by section 101(b) of Public Law 95-223, I continue for 
                1 year, until September 14, 2022, the exercise of those 
                authorities with respect to Cuba, as implemented by the 
                Cuban Assets Control Regulations, 31 CFR part 515.

                The Secretary of the Treasury is authorized and 
                directed to publish this determination in the Federal 
                Register.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    Washington, September 7, 2021

[FR Doc. 2021-19747
Filed 9-9-21; 11:15 am]
Billing code 4811-33-P
<PAGE>   1
                                                                    EXHIBIT 23.1



               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statements on
Form S-8 (No.'s 333-86513, 333-86567 and 333-59803) of Document Sciences
Corporation of our report dated January 14, 2000, with respect to the
consolidated financial statements and financial data schedule of Document
Sciences Corporation included in the Annual Report (Form 10-K) for the year
ended December 31, 1999.


                                                   /s/ ERNST & YOUNG LLP

March 29, 2000
# C_2021029EN.01000101.xml

| 26.1.2021 | EN | Official Journal of the European Union | C 29/1 |
| --- | --- | --- | --- |

26.1.2021

EN

Official Journal of the European Union

C 29/1

---

Non-opposition to a notified concentration

(Case M.10066 — Carlyle/Flender)

(Text with EEA relevance)

(2021/C 29/01)

On 19 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10066. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10066. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
#### ITC Limited et al., Appellants, v Punchgini, Inc., et al., Respondents.

Submitted May 14, 2007;

decided June 5, 2007

Certification of questions by the United States Court of Appeals for the Second Circuit, pursuant to section 500.27 of the Rules of Practice of the Court of Appeals (22 NYCRR 500.27), accepted and the issues presented are to be considered after briefing and argument.

Concur: Chief Judge Kaye and Judges Ciparick, Graffeo, Read, Smith, Pigott and Jones.